Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Levofloxacin may be effective in reducing fever and controlling other symptoms of
neutropenia in patients who are being treated for cancer. It is not yet known whether
levofloxacin is more effective than cefepime in reducing fever and controlling symptoms of
neutropenia.
PURPOSE: Randomized phase III trial to compare the effectiveness of levofloxacin with that of
cefepime in reducing fever and controlling symptoms of neutropenia in patients who are being
treated for cancer.